% | $
Quotes you view appear here for quick access.

Endo International plc Message Board

  • richardsmeed richardsmeed Jun 28, 2013 11:51 PM Flag

    ENDP new update report

    Big research update from Leerink sets price target on ENDP at $48.00. That's a $1billion increase in market cap. They say BDSI's partnered drug BEMA Buprenorphine is the most important asset in ENDP pipeline so they add $1Billion in MKT cap. I read BDSI is submitting an NDA this July for a major competitive drug to Suboxone. The BEMA Bunavail uses 50% less drug per dose then Suboxone and only a 1/3 the amount enters the GI tract so there is a major reduction in side effects such a constipation and diarrhea with a bunch of other big advantages.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
13.69-1.16(-7.81%)Jun 27 4:00 PMEDT